Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes

Diabetes

Volumn 65, Issue 6, 2016, Pages 1690-1698

  McLaughlin, Kerry A ^a   Richardson, Carolyn C ^a,b   Ravishankar, Aarthi ^a   Brigatti, Cristina ^c   Liberati, Daniela ^c   Lampasona, Vito ^c   Piemonti, Lorenzo ^c   Morgan, Diana ^d   Feltbower, Richard G ^d   Christie, Michael R ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LINCOLN   (United Kingdom)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; GLIMA PROTEIN; GLYCOPROTEIN; MEMBRANE PROTEIN; TETRASPANIN 7; UNCLASSIFIED DRUG; TETRASPANIN; TETRASPANIN-7, HUMAN;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; IMMUNOPRECIPITATION; INSULIN DEPENDENT DIABETES MELLITUS; LIQUID CHROMATOGRAPHY; LUNG; MOUSE; NERVE CELL; NONHUMAN; PHASE SEPARATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; ADOLESCENT; ADULT; ANIMAL; BLOOD; BRAIN; HUMAN; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; BRAIN; DIABETES MELLITUS, TYPE 1; HUMANS; LUNG; MEMBRANE GLYCOPROTEINS; MICE; MIDDLE AGED; TETRASPANINS;

EID: 84969821689     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-1058     Document Type: Article

References (28)

1. Bottazzo GF, Doniach D. Islet-cell antibodies (ICA) in diabetes mellitus (evidence of an autoantigen common to all cells in the islet of Langerhans). Ric Clin Lab 1978;8:29-38
2. Weenink SM, Christie MR. Autoantibodies in diabetes. In Autoantibodies and Autoimmunity: Molecular Mechanisms in Health and Disease. Pollard M, Ed. Weinheim, Germany, VCH Verlag GmbH & Co, 2005, p. 321-349
3. Skyler JS. Primary and secondary prevention of type 1 diabetes. Diabet Med 2013;30:161-169
4. Michels A, Zhang L, Khadra A, Kushner JA, Redondo MJ, Pietropaolo M. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention. Pediatr Diabetes 2015;16:465-484
5. Luo X, Herold KC, Miller SD. Immunotherapy of type 1 diabetes: where are we and where should we be going? Immunity 2010;32:488-499
6. Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005;352:2598-2608
7. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, et al.; Type 1 Diabetes TrialNet Anti-CD20 Study Group. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009;361:2143-2152
8. Feutren G, Papoz L, Assan R, et al. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet 1986;2:119-124
9. Palmer JP, Asplin CM, Clemons P, et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983;222:1337-1339
10. Baekkeskov S, Aanstoot HJ, Christgau S, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151-156
11. Payton MA, Hawkes CJ, Christie MR. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 1995;96:1506-1511
12. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007;104:17040-17045
13. Aanstoot HJ, Kang SM, Kim J, et al. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. J Clin Invest 1996;97:2772-2783
14. Winnock F, Christie MR, Batstra MR, et al.; Belgian Diabetes Registry. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies. Diabetes Care 2001;24:1181-1186
15. Roll U, Turck CW, Gitelman SE, et al. Peptide mapping and characterisation of glycation patterns of the glima 38 antigen recognised by autoantibodies in type I diabetic patients. Diabetologia 2000;43:598-608
16. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002;74:5383-5392
17. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003;75:4646-4658
18. Harlow E, Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1988
19. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 2005;6:801-811
20. Lizio M, Harshbarger J, Shimoji H, et al.; FANTOM consortium. Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol 2015;16:22
21. Hald J, Galbo T, Rescan C, et al. Pancreatic islet and progenitor cell surface markers with cell sorting potential. Diabetologia 2012;55:154-165
22. Maecker HT, Todd SC, Levy S. The tetraspanin superfamily: molecular facilitators. FASEB J 1997;11:428-442
23. Berditchevski F. Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci 2001;114:4143-4151
24. Zemni R, Bienvenu T, Vinet MC, et al. A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet 2000;24:167-170
25. Burbelo PD, Ching KH, Mattson TL, Light JS, Bishop LR, Kovacs JA. Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems). Biochem Biophys Res Commun 2007;352:889-895
26. Ziegler AG, Bonifacio E; BABYDIAB-BABYDIET Study Group. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 2012;55:1937-1943
27. Barker JM, Barriga KJ, Yu L, et al.; Diabetes Autoimmunity Study in the Young. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004;89:3896-3902
28. Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013;309:2473-2479